dna chip scanner scanarray lite (Lumonics Inc)
90
Structured Review
Lumonics Inc
dna chip scanner scanarray lite
Dna Chip Scanner Scanarray Lite, supplied by Lumonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+chip+scanner+scanarray+lite/dna+chip+scanner+scanarray+lite/pm40218650-78-6-12
Average 90 stars, based on 1 article reviews
Dna Chip Scanner Scanarray Lite, supplied by Lumonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+chip+scanner+scanarray+lite/dna+chip+scanner+scanarray+lite/pm40218650-78-6-12
Average 90 stars, based on 1 article reviews
dna chip scanner scanarray lite - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Amplification:Article Title: Novel cytomorphologic characteristics suggesting human papillomavirus infection in patients diagnosed as negative for intraepithelial lesion or malignancy and a comparison of diagnostic performance of three human papillomavirus tests. Article Snippet: Department of Pathology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Gyeonggi-do, South Korea Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea Correspondence Han Suk Ryu, MD, PhD, Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, South Korea.. Email: karlnash@naver.com Funding information Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning , Grant/Award Number: NRF2015R1C1A1A01055032; The Korean Society for Cytopathologists , Grant/Award Number: grant number 2014-02 Background: Although the Papanicolaou (Pap) test is the first-line screening method for cervical cancer, it has low sensitivity for detection of human papillomavirus (HPV)-infected cervical lesion compared to the HPV test.. The aims of this study are to determine novel cytomorphologic parameters for HPV infection in patients previously diagnosed as negative for intraepithelial lesion or malignancy (NILM) and to comparatively analyze the detection performance of 3 HPV tests: nested PCR, the DNA Chip test, and the Liquid Beads Microarray (LBMA) assay. Polymerase Chain Reaction:Article Title: Novel cytomorphologic characteristics suggesting human papillomavirus infection in patients diagnosed as negative for intraepithelial lesion or malignancy and a comparison of diagnostic performance of three human papillomavirus tests. Article Snippet: Department of Pathology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Gyeonggi-do, South Korea Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea Correspondence Han Suk Ryu, MD, PhD, Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, South Korea.. Email: karlnash@naver.com Funding information Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning , Grant/Award Number: NRF2015R1C1A1A01055032; The Korean Society for Cytopathologists , Grant/Award Number: grant number 2014-02 Background: Although the Papanicolaou (Pap) test is the first-line screening method for cervical cancer, it has low sensitivity for detection of human papillomavirus (HPV)-infected cervical lesion compared to the HPV test.. The aims of this study are to determine novel cytomorphologic parameters for HPV infection in patients previously diagnosed as negative for intraepithelial lesion or malignancy (NILM) and to comparatively analyze the detection performance of 3 HPV tests: nested PCR, the DNA Chip test, and the Liquid Beads Microarray (LBMA) assay. DNA Hybridization:Article Title: Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology. Article Snippet: Objective Our study used human papillomavirus (HPV) genotyping to assess the disease occurrence probability in women with a lowgrade squamous intraepithelial lesion (LSIL) without histologically confirmed cervical intraepithelial neoplasia grade 2 or worse (CIN2+).. Methods This study investigated CIN2+ incidence in 1986 women from January 2005 to August 2016, including 1123 with LSIL who were histologyproven negative and 863 with LSIL who were histologyproven CIN1.. Baseline highrisk HPV (HRHPV) status was determined using the hybrid capture II assay (HC2), and HRHPV genotype was determined using the HPV DNA chip test (HDC). |
a and HC2 results" width="250" height="auto" />
a and HC2 results" width="100%" height="100%">
